Patent Assignment
Reel/Frame 018816/0817
Merger
Recorded: 2007-01-22
Pages: 17
Assignor
FUJISAWA PHARMACEUTICAL CO., LTD.
Executed: 2005-04-01
Assignee
YAMANOUCHI PHARMACEUTICAL CO., LTD.
3-11 NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, 103-8411, JAPAN
Covered Properties
(3)
Genes Involved in Stroke Response and/or Regulated by FK506, Proteins Encoded Thereby, and Methods of Use
Patent:
6,833,237 →
Application:
10/021,338 →
Methods of Preventing or Treating Brain Ischemia or Brain Injury
STR50 and uses thereof
Application:
10/612,318 →
Publication:
US 2004/0068098
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 25, 2003
From: QUARK BIOTECH, INC.
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 014202/0894 →
Assignment of Assignor's Interest
Jun 25, 2003
From: FAERMAN, ALEXANDER; KACHALSKY, SYLVIA G.; IDELSON, GREGORY HIRSCH
To: QUARK BIOTECH, INC.
Reel/Frame 014202/0896 →
Assignment of Assignor's Interest
Oct 29, 2003
From: KACHALSKY, SYLVIA G.; FAERMAN, ALEXANDER; PEL-OR, YEHUDA
To: QUARK BIOTECH, INC.
Reel/Frame 014632/0831 →
Assignment of Assignor's Interest
Oct 29, 2003
From: QUARK BIOTECH, INC.
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 014632/0842 →
Change of Name
Jan 22, 2007
From: YAMANOUCHI PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 018816/0853 →
Change of Name
Dec 3, 2007
From: QUARK BIOTECH, INC.
To: QUARK PHARMACUTICALS, INC.
Reel/Frame 020206/0703 →